Skip to main content
. 2020 Jul 31;3(10):e202000817. doi: 10.26508/lsa.202000817

Table 2.

Associations of histidine-rich glycoprotein profiles to various traits in set 3.

Trait HPA045005 Bsi0137
Estimatea P-value Estimatea P-value
Aging
 Age 0.010 1.53 × 10−6 0.0017 0.44
 Mortality risk 1.25 6.45 × 10−5 1.03 0.59
Genetic/protein variants
 rs9898 (Pro204Ser) 0.15 2.35 × 10−97 −0.23 1.85 × 10−177
 rs1042464 (Asn493Ile) 0.10 1.9 × 10−44 −0.33 <1 × 10−300
Clinical trait
 APOA1 −0.26 9.47 × 10−6 −0.01 0.76
 APOB −0.23 8.46 × 10−4 0.30 6.81 × 10−10
 C-reactive protein 0.012 7.33 × 10−5 0.0003 0.88
 Glucose −0.028 0.061 0.013 0.21
 Hb −0.008 6.45 × 10−9 0.0004 0.68
 HbA1C −0.047 0.070 0.030 0.092
 High density lipoprotein −0.035 0.41 −0.120 5.65 × 10−5
 Low density lipoprotein −0.044 1.53 × 10−2 0.071 1.90 × 10−8
 TC −0.060 1.37 × 10−4 0.060 4.92 × 10−8
 TG −0.086 2.73 × 10−5 0.074 2.36 × 10−7
a

The estimates from selected models for individual associations. For clinical traits, the values are the estimated slope from linear regression models with adjustment for age and the top single-nucleotide polymorphism (rs9898 for HPA045005 and rs1042464 for BSI0137). Linear models were also used for age and genetic/protein variants, whereas Cox models for mortality risk (more details in the Materials and Methods section). For the trait, hazard ratios are presented in the column.

The two distinct histidin-rich glycoprotein profiles were compared with respect to the association with various traits in set 3, which are 2,999 samples from the TwinGene cohort (Lichtenstein et al, 2002; Magnusson et al, 2013).